These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35041837)

  • 21. Liraglutide attenuates the migration of retinal pericytes induced by advanced glycation end products.
    Lin WJ; Ma XF; Hao M; Zhou HR; Yu XY; Shao N; Gao XY; Kuang HY
    Peptides; 2018 Jul; 105():7-13. PubMed ID: 29746877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of RAGE shedding by activation of G protein-coupled receptors.
    Metz VV; Kojro E; Rat D; Postina R
    PLoS One; 2012; 7(7):e41823. PubMed ID: 22860017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
    Jojima T; Uchida K; Akimoto K; Tomotsune T; Yanagi K; Iijima T; Suzuki K; Kasai K; Aso Y
    Atherosclerosis; 2017 Jun; 261():44-51. PubMed ID: 28445811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases.
    Zhang L; Bukulin M; Kojro E; Roth A; Metz VV; Fahrenholz F; Nawroth PP; Bierhaus A; Postina R
    J Biol Chem; 2008 Dec; 283(51):35507-16. PubMed ID: 18952609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-21-3p regulates AGE/RAGE signalling and improves diabetic atherosclerosis.
    Shao M; Yu M; Zhao J; Mei J; Pan Y; Zhang J; Wu H; Yu M; Liu F; Chen G
    Cell Biochem Funct; 2020 Oct; 38(7):965-975. PubMed ID: 32196704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liraglutide reduces hyperglycemia-induced cardiomyocyte death through activating glucagon-like peptide 1 receptor and targeting AMPK pathway.
    Ma G; Liu Y; Wang Y; Wen Z; Li X; Zhai H; Miao L; Luo J
    J Recept Signal Transduct Res; 2020 Apr; 40(2):133-140. PubMed ID: 32013667
    [No Abstract]   [Full Text] [Related]  

  • 27. Advanced Glycation End Products Affect Osteoblast Proliferation and Function by Modulating Autophagy Via the Receptor of Advanced Glycation End Products/Raf Protein/Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase/Extracellular Signal-regulated Kinase (RAGE/Raf/MEK/ERK) Pathway.
    Meng HZ; Zhang WL; Liu F; Yang MW
    J Biol Chem; 2015 Nov; 290(47):28189-28199. PubMed ID: 26472922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation.
    Sourris KC; Ding Y; Maxwell SS; Al-Sharea A; Kantharidis P; Mohan M; Rosado CJ; Penfold SA; Haase C; Xu Y; Forbes JM; Crawford S; Ramm G; Harcourt BE; Jandeleit-Dahm K; Advani A; Murphy AJ; Timmermann DB; Karihaloo A; Knudsen LB; El-Osta A; Drucker DJ; Cooper ME; Coughlan MT
    Kidney Int; 2024 Jan; 105(1):132-149. PubMed ID: 38069998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulforaphane reduces advanced glycation end products (AGEs)-induced inflammation in endothelial cells and rat aorta.
    Matsui T; Nakamura N; Ojima A; Nishino Y; Yamagishi SI
    Nutr Metab Cardiovasc Dis; 2016 Sep; 26(9):797-807. PubMed ID: 27212619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced glycation end products influence mitochondrial fusion-fission dynamics through RAGE in human aortic endothelial cells.
    Zhang S; Gao Y; Wang J
    Int J Clin Exp Pathol; 2017; 10(7):8010-8022. PubMed ID: 31966653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Neuroprotective Effect of Liraglutide is Mediated by Glucagon-Like Peptide 1 Receptor-Mediated Activation of cAMP/PKA/CREB Pathway.
    Bao Y; Jiang L; Chen H; Zou J; Liu Z; Shi Y
    Cell Physiol Biochem; 2015; 36(6):2366-78. PubMed ID: 26279440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of glucagon-like peptide-1 on advanced glycation endproduct-induced aortic endothelial dysfunction in streptozotocin-induced diabetic rats: possible roles of Rho kinase- and AMP kinase-mediated nuclear factor κB signaling pathways.
    Tang ST; Zhang Q; Tang HQ; Wang CJ; Su H; Zhou Q; Wei W; Zhu HQ; Wang Y
    Endocrine; 2016 Jul; 53(1):107-16. PubMed ID: 26758998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucagon-like peptide-1 (GLP-1) analog liraglutide inhibits endothelial cell inflammation through a calcium and AMPK dependent mechanism.
    Krasner NM; Ido Y; Ruderman NB; Cacicedo JM
    PLoS One; 2014; 9(5):e97554. PubMed ID: 24835252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucagon-like peptide-1 attenuates diabetes-associated osteoporosis in ZDF rat, possibly through the RAGE pathway.
    Cheng Y; Liu P; Xiang Q; Liang J; Chen H; Zhang H; Yang L
    BMC Musculoskelet Disord; 2022 May; 23(1):465. PubMed ID: 35581617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ADAM10 modulates calcitriol-regulated RAGE in cardiomyocytes.
    Lee TW; Kao YH; Lee TI; Chen YJ
    Eur J Clin Invest; 2017 Sep; 47(9):675-683. PubMed ID: 28722189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system.
    Sotokawauchi A; Matsui T; Higashimoto Y; Yamagishi SI
    Diab Vasc Dis Res; 2019 Nov; 16(6):556-561. PubMed ID: 31375034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The shedding-derived soluble receptor for advanced glycation endproducts sustains inflammation during acute Pseudomonas aeruginosa lung infection.
    Antonelli A; Di Maggio S; Rejman J; Sanvito F; Rossi A; Catucci A; Gorzanelli A; Bragonzi A; Bianchi ME; Raucci A
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):354-364. PubMed ID: 27913191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor.
    Ishibashi Y; Matsui T; Maeda S; Higashimoto Y; Yamagishi S
    Cardiovasc Diabetol; 2013 Aug; 12():125. PubMed ID: 23984879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EphrinA/EphA-induced ectodomain shedding of neural cell adhesion molecule regulates growth cone repulsion through ADAM10 metalloprotease.
    Brennaman LH; Moss ML; Maness PF
    J Neurochem; 2014 Jan; 128(2):267-79. PubMed ID: 24117969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADAM10 mediates ectodomain shedding of the betacellulin precursor activated by p-aminophenylmercuric acetate and extracellular calcium influx.
    Sanderson MP; Erickson SN; Gough PJ; Garton KJ; Wille PT; Raines EW; Dunbar AJ; Dempsey PJ
    J Biol Chem; 2005 Jan; 280(3):1826-37. PubMed ID: 15507448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.